GeneDx Holdings Corp. (NASDAQ:WGS)
| Market Cap | 1.97B-46.1% |
| Revenue (ttm) | 454.43M+25.4% |
| Net Income | -106.36M-7664.5% |
| EPS | -3.62-18200.0% |
| Shares Out | 29.82M |
| PE Ratio | n/a |
| Forward PE | 54.99 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 163,311.112 |
| Open | 67.41 |
| Previous Close | 68.53 |
| Day's Range | 64.82 - 67.41 |
| 52-Week Range | 32.21 - 170.87 |
| Beta | 1.97 |
| Analysts | Buy |
| Price Target | 81.00(+22.89%) |
| Earnings Date | Oct 27, 2026 |
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
About WGS
GeneDx Holdings Corp., a genomics company, provides genetic testing services. The company primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. It also develops an AI-based platform for next generation sequencing analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing. GeneDx Holdings Corp. was founded in 2000 and is headquartered in Stamford, Connecticut.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
$WGS stock is featured in our Insider Score Rankings, and Insider Trades datasets.
→ All Stock ListsRecently reported changes in WGS holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by WGS's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
WGS Estimated quarterly lobbying spending
Source: U.S. Senate LDA
WGS Revenue by Segment
| Segment | Revenue | % of All |
|---|---|---|
| Diagnostic test revenue: | $111.89M | 97.77% |
| Other | $2.55M | 2.23% |
As of: Q2 2026 (Jun 30, 2026) · Source: SEC EDGAR (10-Q)
U.S. Patents
New WGS patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to WGS from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in WGS
| ETF | Est. Holding Size |
|---|---|
| ARKKARK Innovation ETF | $104.70M |
| VTIVanguard Morningstar Total Stock Market ETF | $51.55M |
| IWMiShares Russell 2000 ETF | $36.02M |
| ARKGARK Genomic Revolution ETF | $35.91M |
| VXFVanguard Extended Market ETF | $21.63M |
| TSMEThrivent Small-Mid Cap Equity ETF | $13.33M |
Estimated from each fund’s disclosed top holdings × AUM
WGS Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from WGS’s recent data — informational, not investment advice
Insider Score
Our 0–100 Insider Score and the signals behind it.
The live Insider Score and its full factor breakdown are included with Insider Access.
Unlock Insider Score